Sep 27

PQA 02 - PQA 02: Pediatric Cancer, Sarcoma and Cutaneous Tumors, Medical Education & Professional Development, and Health Services Research

2378 - Savings and the Opportunity for Expanded Treatment Access with Advent Biosimilar Denosumab: A U.S. Perspective

04:00pm - 05:00pm ET

Presenter(s)

Kunal Shastri, - Fresenius Kabi SwissBioSim GmbH, Eysins,